Mink Therapeutics Inc (INKT)
Sector • Healthcare Industry • Biotechnology & Pharmaceuticals |
Industry • Biotechnology & Pharmaceuticals |
Sector • Healthcare |
News
AgenT-797: A Beacon of Hope in the Battle Against Severe Acute Respiratory Distress Syndrome
MiNKs AgenT-797 Offers New Hope in Overcoming ICI Resistance in PD-1 Refractory Gastric Cancer
INKT Suffers Operating Shortfall in Third Quarter 2023, but Optimizes Costs for Improved Results
Mink Therapeutics Inc. Struggles with Operating Deficit in Q2 2023
INKT, reduction in the operating behavior throughout the fiscal fourth quarter of 2022